Ghrelin At the Interface of Obesity and Reward

Vitamins and Hormones

Volumn 91, Issue , 2013, Pages 285-323

  Schellekens, Harriët ^a   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Dopamine; Food addiction; Ghrelin; Obesity; Reward

Indexed keywords

EID: 84873862867     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407766-9.00013-4     Document Type: Chapter

References (193)

1. Addolorato G., Capristo E., Leggio L., Ferrulli A., Abenavoli L., Malandrino N., et al. Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcoholism, Clinical and Experimental Research 2006, 30:1933-1937.
2. Ahima R.S., Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Molecular Endocrinology 2008, 22:1023-1031.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC, text revision. 4th ed.
4. Andrews Z.B. Central mechanisms involved in the orexigenic actions of ghrelin. Peptides 2011, 32:2248-2255.
5. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
6. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001, 74:143-147.
7. Avena N.M., Bocarsly M.E., Hoebel B.G., Gold M.S. Overlaps in the nosology of substance abuse and overeating: The translational implications of " food addiction" Current Drug Abuse Reviews 2011, 4:133-139.
8. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neuroscience and Biobehavioral Reviews 2008, 32:20-39.
9. Badaoui A., De Saeger C., Duchemin J., Gihousse D., de Timary P., Starkel P. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. European Journal of Clinical Investigation 2008, 38:397-403.
10. Banks W.A., Burney B.O., Robinson S.M. Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 2008, 29:2061-2065.
11. Banks W.A., Tschop M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. The Journal of Pharmacology and Experimental Therapeutics 2002, 302:822-827.
12. Bassareo V., Di Chiara G. Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. The European Journal of Neuroscience 1999, 11:4389-4397.
13. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. Journal of Medicinal Chemistry 2000, 43:4370-4376.
14. Berthoud H.R. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity (Silver Spring) 2006, 14(Suppl. 5):197S-200S.
15. Bloom S.R., Kuhajda F.P., Laher I., Pi-Sunyer X., Ronnett G.V., Tan T.M., et al. The obesity epidemic: Pharmacological challenges. Molecular Interventions 2008, 8:82-98.
16. Bouchard C. Gene-environment interactions in the etiology of obesity: Defining the fundamentals. Obesity (Silver Spring) 2008, 16(Suppl. 3):S5-S10.
17. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate npy/agrp neurons. Endocrinology 2010, 151:4745-4755.
18. Burger K.S., Stice E. Variability in reward responsivity and obesity: Evidence from brain imaging studies. Current Drug Abuse Reviews 2011, 4:182-189.
19. Calissendorff J., Danielsson O., Brismar K., Rojdmark S. Inhibitory effect of alcohol on ghrelin secretion in normal man. European Journal of Endocrinology 2005, 152:743-747.
20. Calissendorff J., Danielsson O., Brismar K., Rojdmark S. Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects. Metabolism 2006, 55:1625-1629.
21. Camina J.P. Cell biology of the ghrelin receptor. Journal of Neuroendocrinology 2006, 18:65-76.
22. Caminos J.E., Gualillo O., Lago F., Otero M., Blanco M., Gallego R., et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005, 146:1285-1292.
23. Caminos J.E., Nogueiras R., Blanco M., Seoane L.M., Bravo S., Alvarez C.V., et al. Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland. Endocrinology 2003, 144:5089-5097.
24. Carlini V.P., Martini A.C., Schioth H.B., Ruiz R.D., Fiol de Cuneo M., de Barioglio S.R. Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration. Neuroscience 2008, 153:929-934.
25. Carr K.A., Daniel T.O., Lin H., Epstein L.H. Reinforcement pathology and obesity. Current Drug Abuse Reviews 2011, 4:190-196.
26. Castaneda T.R., Tong J., Datta R., Culler M., Tschop M.H. Ghrelin in the regulation of body weight and metabolism. Frontiers in Neuroendocrinology 2010, 31:44-60.
27. Chakrabarti R. Pharmacotherapy of obesity: Emerging drugs and targets. Expert Opinion on Therapeutic Targets 2009, 13:195-207.
28. Chan C.B., Cheng C.H. Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Molecular and Cellular Endocrinology 2004, 214:81-95.
29. Charoenthongtrakul S., Giuliana D., Longo K.A., Govek E., Nolan A., Gagne S., et al. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. The Journal of Pharmacology and Experimental Therapeutics 2009, 329:1178-1186.
30. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 145:2607-2612.
31. Cheng A.Y., Leiter L.A. Metabolic syndrome under fire: Weighing in on the truth. The Canadian Journal of Cardiology 2006, 22:379-382.
32. Chollet C., Meyer K., Beck-Sickinger A.G. Ghrelin-A novel generation of anti-obesity drug: Design, pharmacomodulation and biological activity of ghrelin analogues. Journal of Peptide Science 2009, 15:711-730.
33. Chuang J.C., Perello M., Sakata I., Osborne-Lawrence S., Savitt J.M., Lutter M., et al. Ghrelin mediates stress-induced food-reward behavior in mice. The Journal of Clinical Investigation 2011, 121:2684-2692.
34. Conconi M.T., Nico B., Guidolin D., Baiguera S., Spinazzi R., Rebuffat P., et al. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides 2004, 25:2179-2185.
35. Connelly D.M., Unwin J.W., Taberner P.V. The role of the blood glucose level in determining voluntary ethanol consumption in the LACG and diabetogenic C57BL strains of mice. Biochemical Pharmacology 1983, 32:221-226.
36. Corwin R.L. The face of uncertainty eats. Current Drug Abuse Reviews 2011, 4:174-181.
37. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
38. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nature Medicine 2002, 8:643-644.
39. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
40. Dahlman I., Arner P. Obesity and polymorphisms in genes regulating human adipose tissue. International Journal of Obesity 2007, 31:1629-1641.
41. Dallman M.F. Stress-induced obesity and the emotional nervous system. Trends in Endocrinology and Metabolism 2010, 21:159-165.
42. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
43. Davenport A.P., Bonner T.I., Foord S.M., Harmar A.J., Neubig R.R., Pin J.P., et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacological Reviews 2005, 57:541-546.
44. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., et al. High circulating ghrelin: A potential cause for hyperphagia and obesity in Prader-Willi syndrome. The Journal of Clinical Endocrinology and Metabolism 2002, 87:5461-5464.
45. Depoortere I. Targeting the ghrelin receptor to regulate food intake. Regulatory Peptides 2009, 156:13-23.
46. Dezaki K., Kakei M., Yada T. Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells: Novel signal transduction of ghrelin. Diabetes 2007, 56:2319-2327.
47. Dezaki K., Sone H., Koizumi M., Nakata M., Kakei M., Nagai H., et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006, 55:3486-3493.
48. Diano S. Ghrelin's role in feeding behavior and memory performance. Appetite 2008, 51:363.
49. Dickson S.L., Egecioglu E., Landgren S., Skibicka K.P., Engel J.A., Jerlhag E. The role of the central ghrelin system in reward from food and chemical drugs. Molecular and Cellular Endocrinology 2011, 340:80-87.
50. Dickson S.L., Hrabovszky E., Hansson C., Jerlhag E., Alvarez-Crespo M., Skibicka K.P., et al. Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience 2010, 171:1180-1186.
51. Disse E., Bussier A.L., Deblon N., Pfluger P.T., Tschop M.H., Laville M., et al. Systemic ghrelin and reward: Effect of cholinergic blockade. Physiology and Behavior 2011, 102:481-484.
52. Disse E., Bussier A.L., Veyrat-Durebex C., Deblon N., Pfluger P.T., Tschop M.H., et al. Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content. Physiology and Behavior 2010, 101:277-281.
53. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. The Journal of Clinical Investigation 2004, 114:57-66.
54. Diz-Chaves Y. Ghrelin, appetite regulation, and food reward: Interaction with chronic stress. International Journal of Peptides 2011, 2011:898450.
55. Egecioglu E., Jerlhag E., Salome N., Skibicka K.P., Haage D., Bohlooly Y.M., et al. Ghrelin increases intake of rewarding food in rodents. Addiction Biology 2010, 15:304-311.
56. Egecioglu E., Skibicka K.P., Hansson C., Alvarez-Crespo M., Friberg P.A., Jerlhag E., et al. Hedonic and incentive signals for body weight control. Reviews in Endocrine & Metabolic Disorders 2011, 12:141-151.
57. Eglen R.M., Bosse R., Reisine T. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. Assay and Drug Development Technologies 2007, 5:425-451.
58. Eknoyan G. Adolphe Quetelet (1796-1874)-The average man and indices of obesity. Nephrology, Dialysis, Transplantation 2008, 23:47-51.
59. Finger B.C., Dinan T.G., Cryan J.F. Diet-induced obesity blunts the behavioural effects of ghrelin: Studies in a mouse-progressive ratio task. Psychopharmacology 2012, 220:173-181.
60. Furness J.B., Hunne B., Matsuda N., Yin L., Russo D., Kato I., et al. Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 2011, 193:1-9.
61. Gahete M.D., Cordoba-Chacon J., Hergueta-Redondo M., Martinez-Fuentes A.J., Kineman R.D., Moreno-Bueno G., et al. A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: Potential pathophysiological relevance. PLoS One 2011, 6:e23302.
62. Gearhardt A.N., Corbin W.R., Brownell K.D. Food addiction: An examination of the diagnostic criteria for dependence. Journal of Addiction Medicine 2009, 3:1-7.
63. Gearhardt A.N., Corbin W.R., Brownell K.D. Preliminary validation of the Yale Food Addiction Scale. Appetite 2009, 52:430-436.
64. Gearhardt A.N., White M.A., Potenza M.N. Binge eating disorder and food addiction. Current Drug Abuse Reviews 2011, 4:201-207.
65. Gearhardt A.N., Yokum S., Orr P.T., Stice E., Corbin W.R., Brownell K.D. Neural correlates of food addiction. Archives of General Psychiatry 2011, 68:808-816.
66. Ghigo E., Arvat E., Giordano R., Broglio F., Gianotti L., Maccario M., et al. Biologic activities of growth hormone secretagogues in humans. Endocrine 2001, 14:87-93.
67. Gibbs J., Young R.C., Smith G.P. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 1973, 245:323-325.
68. Gibson E.L. Emotional influences on food choice: Sensory, physiological and psychological pathways. Physiology and Behavior 2006, 89:53-61.
69. Gualillo O., Lago F., Dieguez C. Introducing GOAT: A target for obesity and anti-diabetic drugs?. Trends in Pharmacological Sciences 2008, 29:398-401.
70. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research. Molecular Brain Research 1997, 48:23-29.
71. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6320-6325.
72. Hinney A., Hoch A., Geller F., Schafer H., Siegfried W., Goldschmidt H., et al. Ghrelin gene: Identification of missense variants and a frame shift mutation in extremely obese children and adolescents and healthy normal weight students. The Journal of Clinical Endocrinology and Metabolism 2002, 87:2716.
73. Hoebel B.G. Brain neurotransmitters in food and drug reward. The American Journal of Clinical Nutrition 1985, 42:1133-1150.
74. Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. The Journal of Biological Chemistry 2000, 275:21995-22000.
75. Hosoda H., Kojima M., Mizushima T., Shimizu S., Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. The Journal of Biological Chemistry 2003, 278:64-70.
76. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
77. Iglesias M.J., Pineiro R., Blanco M., Gallego R., Dieguez C., Gualillo O., et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovascular Research 2004, 62:481-488.
78. Jeffery P.L., Duncan R.P., Yeh A.H., Jaskolski R.A., Hammond D.S., Herington A.C., et al. Expression of the ghrelin axis in the mouse: An exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology 2005, 146:432-440.
79. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: Implications for its involvement in brain reward. Addiction Biology 2006, 11:45-54.
80. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addiction Biology 2007, 12:6-16.
81. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Molecular Endocrinology 2006, 20:1772-1785.
82. Kadowaki T., Yamauchi T., Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Letters 2008, 582:74-80.
83. Kageyama H., Kitamura Y., Hosono T., Kintaka Y., Seki M., Takenoya F., et al. Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice. Regulatory Peptides 2008, 145:116-121.
84. Kamegai J., Tamura H., Shimizu T., Ishii S., Tatsuguchi A., Sugihara H., et al. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 2004, 145:3731-3738.
85. Kampov-Polevoy A.B., Garbutt J.C., Khalitov E. Family history of alcoholism and response to sweets. Alcoholism, Clinical and Experimental Research 2003, 27:1743-1749.
86. Kenny P.J. Common cellular and molecular mechanisms in obesity and drug addiction. Nature Reviews. Neuroscience 2011, 12:638-651.
87. Kenny P.J. Reward mechanisms in obesity: New insights and future directions. Neuron 2011, 69:664-679.
88. Kern A., Albarran-Zeckler R., Walsh Heidi E., Smith Roy G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012, 73:317-332.
89. Kim D.J., Yoon S.J., Choi B., Kim T.S., Woo Y.S., Kim W., et al. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol and Alcoholism 2005, 40:76-79.
90. Kineman R.D., Gahete M.D., Luque R.M. Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. Journal of Molecular Endocrinology 2007, 38:511-521.
91. Kohno D., Gao H.Z., Muroya S., Kikuyama S., Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 52:948-956.
92. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
93. Kojima M., Hosoda H., Kangawa K. Purification and distribution of ghrelin: The natural endogenous ligand for the growth hormone secretagogue receptor. Hormone Research 2001, 56(Suppl. 1):93-97.
94. Kojima M., Hosoda H., Kangawa K. Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Practice & Research. Clinical Endocrinology & Metabolism 2004, 18:517-530.
95. Kojima M., Kangawa K. Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone. Nature Clinical Practice. Endocrinology & Metabolism 2006, 2:80-88.
96. Kola B., Korbonits M. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. The Journal of Endocrinology 2009, 202:191-198.
97. Korbonits M., Goldstone A.P., Gueorguiev M., Grossman A.B. Ghrelin-A hormone with multiple functions. Frontiers in Neuroendocrinology 2004, 25:27-68.
98. Korbonits M., Grossman A.B. Ghrelin: Update on a novel hormonal system. European Journal of Endocrinology 2004, 151(Suppl. 1):S67-S70.
99. Korbonits M., Kojima M., Kangawa K., Grossman A.B. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 2001, 14:101-104.
100. Kraus T., Schanze A., Groschl M., Bayerlein K., Hillemacher T., Reulbach U., et al. Ghrelin levels are increased in alcoholism. Alcoholism, Clinical and Experimental Research 2005, 29:2154-2157.
101. Kristenssson E., Sundqvist M., Astin M., Kjerling M., Mattsson H., Dornonville de la Cour C., et al. Acute psychological stress raises plasma ghrelin in the rat. Regulatory Peptides 2006, 134:114-117.
102. Kurose Y., Iqbal J., Rao A., Murata Y., Hasegawa Y., Terashima Y., et al. Changes in expression of the genes for the leptin receptor and the growth hormone-releasing peptide/ghrelin receptor in the hypothalamic arcuate nucleus with long-term manipulation of adiposity by dietary means. Journal of Neuroendocrinology 2005, 17:331-340.
103. Landgren S., Simms J.A., Thelle D.S., Strandhagen E., Bartlett S.E., Engel J.A., et al. The ghrelin signalling system is involved in the consumption of sweets. PLoS One 2011, 6:e18170.
104. Lawrence C.B., Snape A.C., Baudoin F.M., Luckman S.M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 2002, 143:155-162.
105. Leggio L., Addolorato G., Cippitelli A., Jerlhag E., Kampov-Polevoy A.B., Swift R.M. Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcoholism, Clinical and Experimental Research 2011, 35:194-202.
106. Leggio L., Ray L.A., Kenna G.A., Swift R.M. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism, Clinical and Experimental Research 2009, 33:1539-1544.
107. Leite-Moreira A.F., Soares J.B. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discovery Today 2007, 12:276-288.
108. Li S., Loos R.J. Progress in the genetics of common obesity: Size matters. Current Opinion in Lipidology 2008, 19:113-121.
109. Liu G., Fortin J.P., Beinborn M., Kopin A.S. Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. The Journal of Pharmacology and Experimental Therapeutics 2007, 322:1036-1043.
110. Loos R.J., Bouchard C. Obesity-Is it a genetic disorder?. Journal of Internal Medicine 2003, 254:401-425.
111. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 2008, 40:768-775.
112. Lu S., Guan J.L., Wang Q.P., Uehara K., Yamada S., Goto N., et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neuroscience Letters 2002, 321:157-160.
113. Lu S.C., Xu J., Chinookoswong N., Liu S., Steavenson S., Gegg C., et al. An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Molecular Pharmacology 2009, 75:901-907.
114. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neuroscience 2008, 11:752-753.
115. Luttrell L.M. Reviews in molecular biology and biotechnology: Transmembrane signaling by G protein-coupled receptors. Molecular Biotechnology 2008, 39:239-264.
116. Lutz T.A. Amylinergic control of food intake. Physiology and Behavior 2006, 89:465-471.
117. Mager U., Degenhardt T., Pulkkinen L., Kolehmainen M., Tolppanen A.M., Lindstrom J., et al. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance. PLoS One 2008, 3:e2941.
118. Malagon M.M., Luque R.M., Ruiz-Guerrero E., Rodriguez-Pacheco F., Garcia-Navarro S., Casanueva F.F., et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 2003, 144:5372-5380.
119. Marti A., Moreno-Aliaga M.J., Hebebrand J., Martinez J.A. Genes, lifestyles and obesity. International Journal of Obesity and Related Metabolic Disorders 2004, 28(Suppl. 3):S29-S36.
120. Menyhert J., Wittmann G., Hrabovszky E., Szlavik N., Keller E., Tschop M., et al. Distribution of ghrelin-immunoreactive neuronal networks in the human hypothalamus. Brain Research 2006, 1125:31-36.
121. Mikhail N. The metabolic syndrome: Insulin resistance. Current Hypertension Reports 2009, 11:156-158.
122. Mondal M.S., Date Y., Yamaguchi H., Toshinai K., Tsuruta T., Kangawa K., et al. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regulatory Peptides 2005, 126:55-59.
123. Moulin A., Ryan J., Martinez J., Fehrentz J.A. Recent developments in ghrelin receptor ligands. ChemMedChem 2007, 2:1242-1259.
124. Muccioli G., Baragli A., Granata R., Papotti M., Ghigo E. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007, 86:147-164.
125. Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. European Journal of Pharmacology 2002, 440:235-254.
126. Mundinger T.O., Cummings D.E., Taborsky G.J. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006, 147:2893-2901.
127. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-198.
128. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26:2274-2279.
129. Obici S. Minireview: Molecular targets for obesity therapy in the brain. Endocrinology 2009, 150(6):2512-2517.
130. Ochi M., Tominaga K., Tanaka F., Tanigawa T., Shiba M., Watanabe T., et al. Effect of chronic stress on gastric emptying and plasma ghrelin levels in rats. Life Sciences 2008, 82:862-868.
131. Ohgusu H., Shirouzu K., Nakamura Y., Nakashima Y., Ida T., Sato T., et al. Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Biochemical and Biophysical Research Communications 2009, 386:153-158.
132. Oliver G., Wardle J. Perceived effects of stress on food choice. Physiology and Behavior 1999, 66:511-515.
133. Olszewski P.K., Li D., Grace M.K., Billington C.J., Kotz C.M., Levine A.S. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 2003, 24:597-602.
134. Overstreet D.H., Kampov-Polevoy A.B., Rezvani A.H., Murrelle L., Halikas J.A., Janowsky D.S. Saccharin intake predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcoholism, Clinical and Experimental Research 1993, 17:366-369.
135. Parylak S.L., Koob G.F., Zorrilla E.P. The dark side of food addiction. Physiology and Behavior 2011, 104:149-156.
136. Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biological Psychiatry 2010, 67:880-886.
137. Pfluger P.T., Kirchner H., Gunnel S., Schrott B., Perez-Tilve D., Fu S., et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 294:G610-G618.
138. Raspopow K., Abizaid A., Matheson K., Anisman H. Psychosocial stressor effects on cortisol and ghrelin in emotional and non-emotional eaters: Influence of anger and shame. Hormones and Behavior 2010, 58:677-684.
139. Richardson N.R., Gratton A. Changes in medial prefrontal cortical dopamine levels associated with response-contingent food reward: An electrochemical study in rat. The Journal of Neuroscience 1998, 18:9130-9138.
140. Rindi G., Torsello A., Locatelli V., Solcia E. Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system. Experimental Biology and Medicine (Maywood, N.J.) 2004, 229:1007-1016.
141. Sato T., Fukue Y., Teranishi H., Yoshida Y., Kojima M. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology 2005, 146:2510-2516.
142. Schellekens H., Dinan T.G., Cryan J.F. Lean mean fat reducing " ghrelin" machine: Hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 2009, 58:2-16.
143. Schellekens H., et al. Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signalling. J Biol Chem 2012.
144. Schellekens H., et al. Ghrelin signalling and obesity: At the interface of stress, mood and food reward. Pharmacology and therapeutics 2012, 135(3):316-326.
145. Seim I., Collet C., Herington A.C., Chopin L.K. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics 2007, 8:298.
146. Seim I., Josh P., Cunningham P., Herington A., Chopin L. Ghrelin axis genes, peptides and receptors: Recent findings and future challenges. Molecular and Cellular Endocrinology 2011, 340:3-9.
147. Shimbara T., Mondal M.S., Kawagoe T., Toshinai K., Koda S., Yamaguchi H., et al. Central administration of ghrelin preferentially enhances fat ingestion. Neuroscience Letters 2004, 369:75-79.
148. Shrestha Y.B., Wickwire K., Giraudo S. Effect of reducing hypothalamic ghrelin receptor gene expression on energy balance. Peptides 2009, 30:1336-1341.
149. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. The Journal of Clinical Investigation 2002, 109:1429-1436.
150. Skibicka K.P., Dickson S.L. Ghrelin and food reward: The story of potential underlying substrates. Peptides 2011, 32:2265-2273.
151. Skibicka K.P., Hansson C., Alvarez-Crespo M., Friberg P.A., Dickson S.L. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
152. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward: Impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addiction Biology 2012, 17(1):95-107.
153. Soares J.B., Leite-Moreira A.F. Ghrelin, des-acyl ghrelin and obestatin: Three pieces of the same puzzle. Peptides 2008, 29:1255-1270.
154. Soares J.B., Roncon-Albuquerque R., Leite-Moreira A. Ghrelin and ghrelin receptor inhibitors: Agents in the treatment of obesity. Expert Opinion on Therapeutic Targets 2008, 12:1177-1189.
155. Stengel A., Wang L., Tache Y. Stress-related alterations of acyl and desacyl ghrelin circulating levels: Mechanisms and functional implications. Peptides 2011, 32:2208-2217.
156. Stice E., Yokum S., Blum K., Bohon C. Weight gain is associated with reduced striatal response to palatable food. The Journal of Neuroscience 2010, 30:13105-13109.
157. Stoeckel L.E., Weller R.E., Cook E.W., Twieg D.B., Knowlton R.C., Cox J.E. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. NeuroImage 2008, 41:636-647.
158. Stricker-Krongrad A., Richy S., Beck B. Orexins/hypocretins in the ob/ob mouse: Hypothalamic gene expression, peptide content and metabolic effects. Regulatory Peptides 2002, 104:11-20.
159. Sun Y., Ahmed S., Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Molecular and Cellular Biology 2003, 23:7973-7981.
160. Sun Y., Butte N.F., Garcia J.M., Smith R.G. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 2008, 149:843-850.
161. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4679-4684.
162. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine 2004, 1:e62.
163. Tanaka M., Hayashida Y., Nakao N., Nakai N., Nakashima K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochimica et Biophysica Acta 2001, 1522:62-65.
164. Tolle V., Low M.J. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Diabetes 2008, 57:86-94.
165. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003, 144:1506-1512.
166. Tovar S., Nogueiras R., Tung L.Y., Castaneda T.R., Vazquez M.J., Morris A., et al. Central administration of resistin promotes short-term satiety in rats. European Journal of Endocrinology 2005, 153:R1-R5.
167. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
168. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
169. Ukkola O., Ravussin E., Jacobson P., Snyder E.E., Chagnon M., Sjostrom L., et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:3996-3999.
170. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 2004, 25:426-457.
171. Venkova K., Greenwood-Van Meerveld B. Application of ghrelin to gastrointestinal diseases. Current Opinion in Investigational Drugs 2008, 9:1103-1107.
172. Volkow N.D., Wang G.J., Baler R.D. Reward, dopamine and the control of food intake: Implications for obesity. Trends in Cognitive Sciences 2010, 15:37-46.
173. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Baler R. Food and drug reward: Overlapping circuits in human obesity and addiction. Current Topics in Behavioral Neurosciences 2012, 11:1-24.
174. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. The Lancet 2001, 357:354-357.
175. Wang G.J., Volkow N.D., Thanos P.K., Fowler J.S. Imaging of brain dopamine pathways: Implications for understanding obesity. Journal of Addiction Medicine 2009, 3:8-18.
176. Wells T. Ghrelin-Defender of fat. Progress in Lipid Research 2009, 48:257-274.
177. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics 2009, 41:25-34.
178. Wise R.A. Role of brain dopamine in food reward and reinforcement. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2006, 361:1149-1158.
179. Wise R.A., Rompre P.P. Brain dopamine and reward. Annual Review of Psychology 1989, 40:191-225.
180. Wortley K.E., Anderson K.D., Garcia K., Murray J.D., Malinova L., Liu R., et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8227-8232.
181. Wortley K.E., del Rincon J.P., Murray J.D., Garcia K., Iida K., Thorner M.O., et al. Absence of ghrelin protects against early-onset obesity. The Journal of Clinical Investigation 2005, 115:3573-3578.
182. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. The Journal of Clinical Endocrinology and Metabolism 2001, 86:5992.
183. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
184. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
185. Yang J., Zhao T.J., Goldstein J.L., Brown M.S. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10750-10755.
186. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
187. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
188. Zhao T.J., Sakata I., Li R.L., Liang G., Richardson J.A., Brown M.S., et al. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15868-15873.
189. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. The Journal of Comparative Neurology 2006, 494:528-548.
190. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. The Journal of Clinical Investigation 2005, 115:3564-3572.
191. Zimmermann U.S., Buchmann A., Steffin B., Dieterle C., Uhr M. Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addiction Biology 2007, 12:17-21.
192. Zito K.A., Vickers G., Telford L., Roberts D.C. Experimentally induced glucose intolerance increases oral ethanol intake in rats. Alcohol 1984, 1:257-261.
193. Zorrilla E.P., Iwasaki S., Moss J.A., Chang J., Otsuji J., Inoue K., et al. Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13226-13231.